Drug Shortage Report for TEVA-NABILONE

Last updated on 2020-05-29 History
Report ID 115547
Drug Identification Number 02384892
Brand name TEVA-NABILONE
Common or Proper name NABILONE 1MG CAPS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) NABILONE
Strength(s) 1.0MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 50
ATC code A04AD
ATC description ANTIEMETICS AND ANTINAUSEANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-05-20
Estimated end date 2020-07-31
Actual end date
Shortage status Actual shortage
Updated date 2020-05-29
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-05-29 French Compare
v3 2020-05-29 English Compare
v2 2020-05-21 French Compare
v1 2020-05-21 English Compare